Escient Pharmaceuticals

Third Harmonic Bio

This biopharmaceutical company develops oral small-molecule inhibitors for patients with mast-cell-mediated inflammatory diseases such as chronic urticaria and asthma.

DICE Therapeutics

This biopharmaceutical company develops oral small molecule medicines for patients with chronic immunological and inflammatory diseases such as psoriasis.

Orvida Pharma (Formerly Kamari)

This biotechnology company develops oral and topical small-molecule treatments for patients with rare and severe genetic skin diseases and chronic itch conditions.

Arcutis Biotherapeutics

This biopharmaceutical company develops and commercialises topical treatments for patients with chronic inflammatory skin diseases such as psoriasis, eczema, and seborrhoeic dermatitis.

Principia Biopharma

The company develops oral small molecule therapies for patients with immune-mediated diseases and cancer.

Scenic Biotech

This company develops disease-modifying small molecule therapeutics for patients with rare genetic and neurodegenerative disorders using its proprietary genetic modifier discovery platform.

Augustine Therapeutics

This company develops small molecule inhibitors to treat patients with neuromuscular, neurodegenerative and cardio-metabolic diseases.

Forward Therapeutics

The company develops oral small-molecule medicines for patients with chronic immunological and inflammatory disorders.